Suzana Anjum

Suzana Anjum

Auto-generated profile, based on publicly available information

Suzana Anjum

Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
PEPhilipp Erhart
Philipp Erhart
TCTina Cohnert
Tina Cohnert
GSGregor Siegl
Gregor Siegl
SASuzana Anjum
Suzana Anjum
IMImke Matthys
Imke Matthys
Stefano AncettiStefano Ancetti
Stefano Ancetti
Carotid paragangliomas (CPGLs) are rare neuroendocrine tumours. Previous studies have emphasised the high prevalence of hereditary genetic variants. This study specifically examined the clinical course of CPGLs in patients with pathogenic disease causing genetic variants (PV) and unspecific non-pathogenic genetic findings (non-PV) currently not associated with CPGLs. This was a multicentre, retrospective, exploratory study. Whole genome, exome, or gene panel sequencing was performed in participating centres in the clinical diagnostic setting. Genetic variants were described following appropriate reporting standards. Re-evaluation regarding their pathogenicity was performed according to the American College of Medical Genetics and Genomics guidelines. Individuals with benign, likely benign, or variants of unknown significance were assigned to the non-PV group, and individuals with likely pathogenic or pathogenic variants were assigned to the PV group. Relevant clinical variables and follow up data were collected to relate clinical outcomes to genetic findings. A total of 173 patients were analysed, of which 45.1% had PVs in respective candidate genes for paraganglioma, including the succinate dehydrogenase (SDH) complex subunit D (n = 56), B (n = 17), C (n = 3), A (n = 1) and von Hippel-Lindau (n = 1) genes. Those with PVs were younger (median age 44 years vs. 60 years; p< .001), had a greater likelihood of multilocular paraganglioma manifestation (47 vs. 2; p< .001), and more frequently had local recurrences after surgical removal (20 vs. 1; p< .001). Tumour recurrence occurred after a median of 8.5 years following surgery. Bilateral CPGLs (36 vs. 2; p< .001) and a positive familial history of paraganglioma (28 vs. 4; p< .001) were associated with PVs. Genetic variants, especially in the SDHD gene, were common and associated with worse CPGL outcomes, thus emphasising the benefit of genetic diagnostics and counselling.

30 November 2021 in Academic Medicine
Verified
Journal Article
Closed access
SASuzana Anjum
Suzana Anjum
HCHannah Callaghan
Hannah Callaghan
BJBradley Johnson
Bradley Johnson